Natural history of venous thromboembolism

被引:803
作者
Kearon, C [1 ]
机构
[1] Henderson Gen Hosp, McMaster Clin, Hamilton, ON L8V 1C3, Canada
基金
美国国家卫生研究院;
关键词
embolism; epidemiology; risk factors; thrombosis; veins;
D O I
10.1161/01.CIR.0000078464.82671.78
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most deep vein thromboses (DVTs) start in the calf, and most probably resolve spontaneously. Thrombi that remain confined to the calf rarely cause leg symptoms or symptomatic pulmonary embolism ( PE). The probability that calf DVT will extend to involve the proximal veins and subsequently cause PE increases with the severity of the initiating prothrombotic stimulus. Although acute venous thromboembolism (VTE) usually presents with either leg or pulmonary symptoms, most patients have thrombosis at both sites at the time of diagnosis. Proximal DVTs resolve slowly during treatment with anticoagulants, and thrombi remain detectable in half of the patients after a year. Resolution of DVT is less likely in patients with a large initial thrombus or cancer. About 10% of patients with symptomatic DVTs develop severe post-thrombotic syndrome within 5 years, and recurrent ipsilateral DVT increases this risk. About 10% of PEs are rapidly fatal, and an additional 5% cause death later, despite diagnosis and treatment. About 50% of diagnosed PEs are associated with right ventricular dysfunction, which is associated with a approximate to5-fold greater in-hospital mortality. There is approximate to50% resolution of PE after 1 month of treatment, and perfusion eventually returns to normal in two thirds of patients. About 5% of treated patients with PE develop pulmonary hypertension as a result of poor resolution. After a course of treatment, the risk of recurrent thrombosis is higher (ie, approximate to 10% per patient-year) in patients without reversible risk factors, in those with cancer, and in those with prothrombotic biochemical abnormalities such as antiphospholipid antibodies and homozygous factor V Leiden.
引用
收藏
页码:I22 / I30
页数:9
相关论文
共 141 条
  • [81] LAGERSTEDT CI, 1985, LANCET, V2, P515
  • [82] Medical progress: The antiphospholipid syndrome.
    Levine, JS
    Branch, DW
    Rauch, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) : 752 - 763
  • [83] A RANDOMIZED TRIAL OF A SINGLE BOLUS DOSAGE REGIMEN OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM
    LEVINE, M
    HIRSH, J
    WEITZ, J
    CRUICKSHANK, M
    NEEMEH, J
    TURPIE, AG
    GENT, M
    [J]. CHEST, 1990, 98 (06) : 1473 - 1479
  • [84] LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606
  • [85] LINDHAGEN A, 1985, ACTA MED SCAND, V217, P389
  • [86] The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg
    Lindmarker, P
    Schulman, S
    [J]. JOURNAL OF INTERNAL MEDICINE, 2000, 247 (05) : 601 - 606
  • [87] Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684
  • [88] LONG-TERM HEMODYNAMIC AND CLINICAL SEQUELAE OF LOWER-EXTREMITY DEEP-VEIN THROMBOSIS
    LINDNER, DJ
    EDWARDS, JM
    PHINNEY, ES
    TAYLOR, LM
    PORTER, JM
    [J]. JOURNAL OF VASCULAR SURGERY, 1986, 4 (05) : 436 - 442
  • [89] Inherited thrombophilic risk factors and venous thromboembolism - Distinct role in peripheral deep venous thrombosis and pulmonary embolism
    Margaglione, M
    Brancaccio, V
    De Lucia, D
    Martinelli, I
    Ciampa, A
    Grandone, E
    Di Minno, G
    [J]. CHEST, 2000, 118 (05) : 1405 - 1411
  • [90] MAYNARD MJ, 1991, CLIN ORTHOP RELAT R, V273, P125